Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Nektar Therapeutics (NKTR) Has Jumped To A New High On Study Results
Nektar Therapeutics (NKTR) Has Jumped To A New High On Study Results
Nektar Therapeutics (NKTR) Has Jumped To A New High On Study Results
Submitted by
admin
on November 13, 2017 - 10:54am
Source:
NASDAQ.com
News Tags:
Nektar
NKTR-214
Opdivdo
Bristol-Myers Squibb
Headline:
Nektar Therapeutics (NKTR) Has Jumped To A New High On Study Results
Do Not Allow Advertisers to Use My Personal information
